Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution.
作者： P Bernasconi , C Klersy , M Boni , P M Cavigliano , S Calatroni
关键词:
摘要: … One of the aims of the present study was to check whether IPSS scores and IPSS cytogenetic categories significantly influenced OS and HRs for MDS/AML progression in a series of …
nature.com
elsevier.com
sci-hub.se 参考文章(42)
GF Sanz, MA Sanz, T Vallespi, MC Canizo, M Torrabadella, S Garcia, D Irriguible, JF San Miguel, Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood. ,vol. 74, pp. 395- 408 ,(1989) , 10.1182/BLOOD.V74.1.395.395
Ohyashiki K, Kuramoto A, Hotta T, Hirai H, Abe T, Asano S, Toyama K, Hirashima K, Kuriya S, Yoshida Y, Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia. ,vol. 7, pp. 499- 508 ,(1993)
Peter Greenberg, Christopher Cox, Michelle M. LeBeau, Pierre Fenaux, Pierre Morel, Guillermo Sanz, Miguel Sanz, Teresa Vallespi, Terry Hamblin, David Oscier, Kazuma Ohyashiki, Keisuke Toyama, Carlo Aul, Ghulam Mufti, John Bennett, International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes Blood. ,vol. 89, pp. 2079- 2088 ,(1997) , 10.1182/BLOOD.V89.6.2079
GW Dewald, MP Davis, RV Pierre, JR O'Fallon, HC Hoagland, Clinical characteristics and prognosis of 50 patients with a myeloproliferative syndrome and deletion of part of the long arm of chromosome 5 Blood. ,vol. 66, pp. 189- 197 ,(1985) , 10.1182/BLOOD.V66.1.189.189
Stephen H. Nantel, Hans-G. Klingemann, Donna L. Forrest, Cynthia L. Toze, Heather J. Sutherland, Donna E. Hogge, Sheldon C. Naiman, Alan Le, Daphne A. Brockington, Michael J. Barnett, Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation. Blood. ,vol. 92, pp. 1910- 1917 ,(1998) , 10.1182/BLOOD.V92.6.1910
V. Parlier, G. van Melle, Ph. Beris, P.M. Schmidt, A. Tobler, E. Haller, M.Jotterand Bellomo, Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome Cancer Genetics and Cytogenetics. ,vol. 78, pp. 219- 231 ,(1994) , 10.1016/0165-4608(94)90094-9
RH Jacobs, MA Cornbleet, JW Vardiman, RA Larson, MM Le Beau, JD Rowley, Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes Blood. ,vol. 67, pp. 1765- 1772 ,(1986) , 10.1182/BLOOD.V67.6.1765.1765
Margriet Oosterveld, Shulamiet H. Wittebol, Wim A. J. G. Lemmens, Bart A. L. M. Kiemeney, Ashuman Çatik, Petra Muus, Anton V. M. B. Schattenberg, Theo J. M. De Witte, The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups. British Journal of Haematology. ,vol. 123, pp. 81- 89 ,(2003) , 10.1046/J.1365-2141.2003.04544.X
F Sole, F Prieto, L Badia, S Woessner, L Florensa, MR Caballin, MD Coll, C Besses, J Sans-Sabrafen, Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes Cancer Genetics and Cytogenetics. ,vol. 64, pp. 12- 20 ,(1992) , 10.1016/0165-4608(92)90315-Y
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25